Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Fiers

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Scientific Reports|April 14, 2016
Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategiesMichael Schotsaert, Tine Ysenbaert, Anouk Smet, et al.
Antiviral Research|March 5, 2017
Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infectionJochen Pendzialek, Kenny Roose, Anouk Smet, et al.
Plos One|May 15, 2015
Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli PhagesLei Deng, Lorena Itatí Ibañez, Veronique Van den Bossche, et al.
Plos One|April 5, 2013
Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2eHana Kammoun, Xavier Roux, Dominique Raze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2010
Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protectionKarim El Bakkouri, Francis Descamps, Marina De Filette, et al.
Plos One|March 28, 2015
A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibodySarah De Baets, Judith Verhelst, Silvie Van den Hoecke, et al.
Vaccine|April 13, 2011
A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virusDubravka Grdic Eliasson, Anja Helgeby, Karin Schön, et al.
Plos One|March 26, 2013
M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza ALorena Itatí Ibañez, Kenny Roose, Marina De Filette, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 27, 2017
Oral delivery of Escherichia coli persistently infected with M2e-displaying bacteriophages partially protects against influenza A virusLei Deng, Kenny Roose, Emma R Job, et al.
International Journal of Cancer|February 13, 2004
Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokineticsPeter Brouckaert, Nozomi Takahashi, Sandra T van Tiel, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Scientific Reports|April 14, 2016
Long-Lasting Cross-Protection Against Influenza A by Neuraminidase and M2e-based immunization strategiesMichael Schotsaert, Tine Ysenbaert, Anouk Smet, et al.
Antiviral Research|March 5, 2017
Bispecific T cell engaging antibody constructs targeting a universally conserved part of the viral M2 ectodomain cure and prevent influenza A virus infectionJochen Pendzialek, Kenny Roose, Anouk Smet, et al.
Plos One|May 15, 2015
Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli PhagesLei Deng, Lorena Itatí Ibañez, Veronique Van den Bossche, et al.
Plos One|April 5, 2013
Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2eHana Kammoun, Xavier Roux, Dominique Raze, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 21, 2010
Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protectionKarim El Bakkouri, Francis Descamps, Marina De Filette, et al.
Plos One|March 28, 2015
A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibodySarah De Baets, Judith Verhelst, Silvie Van den Hoecke, et al.
Vaccine|April 13, 2011
A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virusDubravka Grdic Eliasson, Anja Helgeby, Karin Schön, et al.
Plos One|March 26, 2013
M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza ALorena Itatí Ibañez, Kenny Roose, Marina De Filette, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 27, 2017
Oral delivery of Escherichia coli persistently infected with M2e-displaying bacteriophages partially protects against influenza A virusLei Deng, Kenny Roose, Emma R Job, et al.
International Journal of Cancer|February 13, 2004
Tumor necrosis factor-alpha augmented tumor response in B16BL6 melanoma-bearing mice treated with stealth liposomal doxorubicin (Doxil) correlates with altered Doxil pharmacokineticsPeter Brouckaert, Nozomi Takahashi, Sandra T van Tiel, et al.
Pageof 4